General
AstraZeneca keeps backing of Australian politicians and health advisors despite blood clot concerns
Australian health advisors and the government remain committed to the rollout of the AstraZeneca COVID-19 vaccine, despite safety concerns overseas and on the backbench.
Key points:
- Germany, France and other countries have paused their AstraZeneca rollouts after anecdotal reports of blood clots
- There is no evidence linking the clots to the vaccine, and a report from the European Medicines Agency is underway
- Australia is set to manufacture 50 million doses of the vaccine
Multiple European countries, including Spain, Italy, France, Germany and Portugal, have suspended the use of the AstraZeneca vaccine, following reports that people who received it went on to form blood clots.
Treasurer Josh Frydenberg said on Tuesday morning there was no…
Continue Reading
-
Business15 hours agoTop brokers name 3 ASX shares to buy next week 16 November 2025
-
Business18 hours ago3 US dividend stocks that can boost an ASX retirement portfolio
-
General21 hours agoPope Leo XIV urges Hollywood actors to resist algorithms and save neighbourhood cinemas
-
General11 hours agoAccusations of secrecy, abuse of power fly as WA Labor wades through third term